E131K (p.Glu131Lys) variant of AKT3 (Q9Y243)
E131K (p.Glu131Lys) in AKT3 (Q9Y243) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.57 / 1. The record also includes population frequency data.
E131K (p.Glu131Lys) variant details
- p.Glu131Lys
- NCI-TCGA Cosmic COSV5562
- cosmic curated COSV55622
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.572
- MetaLR 0.06
- MetaSVM -1.09
- CADD 22.30
- PolyPhen-2 0.01
- SIFT 0.00
- UniProt: Variant assessed as somatic; moderate impact.
- Most common in the Non-Finnish European population (allele frequency 9e-07)